Ah, also doch ... Ja, Cortison ist da einfach unersätzlich! Aber falls Du mal eine Alternative zum Fastject brauchst: es gibt ja jetzt auch den unaussprechlichen, aber gut funktionierenden "EurNeffy" (Adrenalin-1x- Nasenspray, Wirkung offenbar adäquat zum Pen)
July 11, 2026 at 10:37 AM
Ah, also doch ... Ja, Cortison ist da einfach unersätzlich! Aber falls Du mal eine Alternative zum Fastject brauchst: es gibt ja jetzt auch den unaussprechlichen, aber gut funktionierenden "EurNeffy" (Adrenalin-1x- Nasenspray, Wirkung offenbar adäquat zum Pen)
EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
Read the full press release here:
ir.ars-pharma.com/news-release...
#FoodAllergy #Allergy #neffy #ARSPharmaceuticals #Epinephrine #Adrenaline
Read the full press release here:
ir.ars-pharma.com/news-release...
#FoodAllergy #Allergy #neffy #ARSPharmaceuticals #Epinephrine #Adrenaline
July 19, 2025 at 3:40 AM
EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
Read the full press release here:
ir.ars-pharma.com/news-release...
#FoodAllergy #Allergy #neffy #ARSPharmaceuticals #Epinephrine #Adrenaline
Read the full press release here:
ir.ars-pharma.com/news-release...
#FoodAllergy #Allergy #neffy #ARSPharmaceuticals #Epinephrine #Adrenaline
MHRA approves adrenaline nasal spray - the first needle-free emergency treatment for anaphylaxis in the UK
#Pharmsky #Medsky
www.gov.uk/government/n...
#Pharmsky #Medsky
www.gov.uk/government/n...
MHRA approves adrenaline nasal spray - the first needle-free emergency treatment for anaphylaxis in the UK
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 18 July 2025, approved adrenaline (epinephrine) nasal spray (EURneffy) to be used for the emergency treatment of serious aller...
www.gov.uk
July 22, 2025 at 10:01 AM
MHRA approves adrenaline nasal spray - the first needle-free emergency treatment for anaphylaxis in the UK
#Pharmsky #Medsky
www.gov.uk/government/n...
#Pharmsky #Medsky
www.gov.uk/government/n...
#Wales has recommended #ALK's #EURneffy #nasalspray as the first needle-free option for the #emergency treatment of severe #allergicreactions, including #anaphylaxis – more than a year after it was approved for marketing in the #UK.
pharmaphorum.com/news/wales-t...
pharmaphorum.com/news/wales-t...
Wales takes UK lead on needle-free anaphylaxis prevention
Wales has recommended ALK's EURneffy nasal spray as a needle-free option for emergency treatment of severe allergic reactions, including anaphylaxis.
pharmaphorum.com
September 17, 2026 at 8:19 AM
#Wales has recommended #ALK's #EURneffy #nasalspray as the first needle-free option for the #emergency treatment of severe #allergicreactions, including #anaphylaxis – more than a year after it was approved for marketing in the #UK.
pharmaphorum.com/news/wales-t...
pharmaphorum.com/news/wales-t...
🔟 En junio, la EMA autorizó la venta del primer medicamento por vía nasal para tratar de urgencia las reacciones alérgicas graves que pueden provocar un choque anafiláctico. Hasta ahora, el tratamiento se hace con una inyección intramuscular de adrenalina.
sciencemediacentre.es/la-ema-da-lu...
sciencemediacentre.es/la-ema-da-lu...
La EMA da luz verde al primer aerosol nasal de adrenalina para el tratamiento urgente de reacciones alérgicas
El Comité de Medicamentos de Uso Humano (CHMP) de la Agencia Europa del Medicamento (EMA) ha recomendado la concesión de autorización de comercialización en la Unión Europea para Eurneffy (epinefrina)...
sciencemediacentre.es
December 27, 2024 at 11:50 AM
🔟 En junio, la EMA autorizó la venta del primer medicamento por vía nasal para tratar de urgencia las reacciones alérgicas graves que pueden provocar un choque anafiláctico. Hasta ahora, el tratamiento se hace con una inyección intramuscular de adrenalina.
sciencemediacentre.es/la-ema-da-lu...
sciencemediacentre.es/la-ema-da-lu...
An epinephrine (adrenaline) formulation used nasally is now licensed for anaphylaxis in the EU (‘EURneffy’) & in the USA (‘neffy’)
This provides an alternative to the EpiPen for nut & other acute allergic reactions.
Not approved yet in the UK, but hopefully next year @AllergyUK1
This provides an alternative to the EpiPen for nut & other acute allergic reactions.
Not approved yet in the UK, but hopefully next year @AllergyUK1
December 3, 2024 at 8:01 AM
An epinephrine (adrenaline) formulation used nasally is now licensed for anaphylaxis in the EU (‘EURneffy’) & in the USA (‘neffy’)
This provides an alternative to the EpiPen for nut & other acute allergic reactions.
Not approved yet in the UK, but hopefully next year @AllergyUK1
This provides an alternative to the EpiPen for nut & other acute allergic reactions.
Not approved yet in the UK, but hopefully next year @AllergyUK1
Was ich an dem EurNeffy toll finde, ist nicht nur, dass er eben klein ist und in jede Hosentasche passt, sondern dass (was natürlich nicht Dein Problem, aber vielleicht eines im Umfeld ist) für Laien die Hemmschwelle bei der Anwendung geringer ist. Es kann sich eben nicht jede*r gut selbst spritzen
July 11, 2026 at 10:49 AM
Was ich an dem EurNeffy toll finde, ist nicht nur, dass er eben klein ist und in jede Hosentasche passt, sondern dass (was natürlich nicht Dein Problem, aber vielleicht eines im Umfeld ist) für Laien die Hemmschwelle bei der Anwendung geringer ist. Es kann sich eben nicht jede*r gut selbst spritzen
The first needle-free adrenaline (epinephrine) nasal spray for anaphylaxis has been approved by the Medicines and Healthcare products Regulatory Agency
#ukpharmacy #anaphylaxis
#ukpharmacy #anaphylaxis
MHRA approves first needle-free emergency treatment for anaphylaxis
The first needle-free adrenaline (epinephrine) nasal spray for anaphylaxis has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA). EURneffy, which is marketed by…
buff.ly
July 22, 2025 at 2:40 PM
The first needle-free adrenaline (epinephrine) nasal spray for anaphylaxis has been approved by the Medicines and Healthcare products Regulatory Agency
#ukpharmacy #anaphylaxis
#ukpharmacy #anaphylaxis
First adrenaline nasal spray approved by the MHRSA for use in emergencies to treat serious allergic reactions
www.gov.uk/government/n...
www.gov.uk/government/n...
MHRA approves adrenaline nasal spray - the first needle-free emergency treatment for anaphylaxis in the UK
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 18 July 2025, approved adrenaline (epinephrine) nasal spray (EURneffy) to be used for the emergency treatment of serious aller...
www.gov.uk
July 18, 2025 at 3:45 PM
First adrenaline nasal spray approved by the MHRSA for use in emergencies to treat serious allergic reactions
www.gov.uk/government/n...
www.gov.uk/government/n...
🗞️ A new route in anaphylaxis treatment: Intranasal adrenaline. Read about it in PCRU!
This article explains how to use the MHRA-approved EURneffy and details the monitoring, access and positioning. https://ow.ly/Qw3G50Zy1uc
This article explains how to use the MHRA-approved EURneffy and details the monitoring, access and positioning. https://ow.ly/Qw3G50Zy1uc
August 28, 2026 at 9:45 AM
🗞️ A new route in anaphylaxis treatment: Intranasal adrenaline. Read about it in PCRU!
This article explains how to use the MHRA-approved EURneffy and details the monitoring, access and positioning. https://ow.ly/Qw3G50Zy1uc
This article explains how to use the MHRA-approved EURneffy and details the monitoring, access and positioning. https://ow.ly/Qw3G50Zy1uc
First needle-free treatment for life-threatening allergic reactions will be made available in the UK as a nasal spray
The medicines regulator has approved the drug EURneffy for emergency use in a move welcomed by allergy campaigners.
The medicines regulator has approved the drug EURneffy for emergency use in a move welcomed by allergy campaigners.
First needle-free treatment for life-threatening allergic reactions
The medicines regulator has approved the drug EURneffy for emergency use in a move welcomed by allergy campaigners.
www.dailymail.co.uk
July 18, 2025 at 6:19 PM
First needle-free treatment for life-threatening allergic reactions will be made available in the UK as a nasal spray
The medicines regulator has approved the drug EURneffy for emergency use in a move welcomed by allergy campaigners.
The medicines regulator has approved the drug EURneffy for emergency use in a move welcomed by allergy campaigners.
#Adrenalin bei #Anaphylaxie: sprühen statt spritzen?
Erstmals ist mit EURNEFFY ein Adrenalin-Nasenspray alternativ zur i.m.-Injektion im Handel. Welche Daten gibt es dazu?
www.arznei-telegramm.de/html/2025_06...
Erstmals ist mit EURNEFFY ein Adrenalin-Nasenspray alternativ zur i.m.-Injektion im Handel. Welche Daten gibt es dazu?
www.arznei-telegramm.de/html/2025_06...
Adrenalin bei Anaphylaxie: sprühen statt spritzen?
Erstmals ist mit EURNEFFY ein Adrenalin-Nasenspray alternativ zur i.m.-Injektion im Handel. Welche Daten gibt es dazu?
www.arznei-telegramm.de
June 18, 2025 at 7:20 AM
#Adrenalin bei #Anaphylaxie: sprühen statt spritzen?
Erstmals ist mit EURNEFFY ein Adrenalin-Nasenspray alternativ zur i.m.-Injektion im Handel. Welche Daten gibt es dazu?
www.arznei-telegramm.de/html/2025_06...
Erstmals ist mit EURNEFFY ein Adrenalin-Nasenspray alternativ zur i.m.-Injektion im Handel. Welche Daten gibt es dazu?
www.arznei-telegramm.de/html/2025_06...
Feed: "Business-News-Today.com"
By: Soujanya Ravi on Thursday, February 5, 2026
By: Soujanya Ravi on Thursday, February 5, 2026
How EMA’s support for EURneffy 1 mg could disrupt Europe’s pediatric epinephrine market
EMA backs EURneffy 1 mg for pediatric anaphylaxis. Find out how ARS Pharmaceuticals and ALK-Abelló could reshape Europe’s allergy care landscape.
business-news-today.com
February 5, 2026 at 4:10 PM
Feed: "Business-News-Today.com"
By: Soujanya Ravi on Thursday, February 5, 2026
By: Soujanya Ravi on Thursday, February 5, 2026
Feed: "PharmaTimes"
By: Esme Needham on Monday, February 2, 2026
By: Esme Needham on Monday, February 2, 2026
ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
Anaphylaxis is the most serious type of allergic reaction and occurs more commonly in boys
pharmatimes.com
February 3, 2026 at 4:34 AM
Feed: "PharmaTimes"
By: Esme Needham on Monday, February 2, 2026
By: Esme Needham on Monday, February 2, 2026
MHRA approves adrenaline nasal spray - the first needle-free emergency treatment for anaphylaxis in the UK
MHRA approves adrenaline nasal spray - the first needle-free emergency treatment for anaphylaxis in the UK
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 18 July 2025, approved adrenaline (epinephrine) nasal spray (EURneffy) to be used for the emergency treatment of serious aller...
www.gov.uk
July 18, 2025 at 1:27 PM
MHRA approves adrenaline nasal spray - the first needle-free emergency treatment for anaphylaxis in the UK
Advancements in Nasal Sprays Fueled by Particle Analysis
The Nasal Spray Market: Innovations and Future Directions A Booming Market Recent estimates suggest that the global nasal spray market is poised to surpass $59.4 billion by 2032. This growth trajectory underscores a significant paradigm…
The Nasal Spray Market: Innovations and Future Directions A Booming Market Recent estimates suggest that the global nasal spray market is poised to surpass $59.4 billion by 2032. This growth trajectory underscores a significant paradigm…
Advancements in Nasal Sprays Fueled by Particle Analysis
The Nasal Spray Market: Innovations and Future Directions A Booming Market Recent estimates suggest that the global nasal spray market is poised to surpass $59.4 billion by 2032. This growth trajectory underscores a significant paradigm shift in drug delivery methods, particularly highlighted by the UK Medicines and Healthcare products Regulatory Agency’s approval of EURneffy®, a revolutionary needle-free alternative to the EpiPen®.
capitalisticapproach.com
January 27, 2026 at 1:10 PM
Advancements in Nasal Sprays Fueled by Particle Analysis
The Nasal Spray Market: Innovations and Future Directions A Booming Market Recent estimates suggest that the global nasal spray market is poised to surpass $59.4 billion by 2032. This growth trajectory underscores a significant paradigm…
The Nasal Spray Market: Innovations and Future Directions A Booming Market Recent estimates suggest that the global nasal spray market is poised to surpass $59.4 billion by 2032. This growth trajectory underscores a significant paradigm…